{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:43:27Z","timestamp":1722037407364},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T00:00:00Z","timestamp":1447286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142539","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T20:07:30Z","timestamp":1447358850000},"page":"e0142539","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro"],"prefix":"10.1371","volume":"10","author":[{"given":"Lucie","family":"F\u00e9n\u00e9ant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptiste","family":"Fouquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Helle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Belouzard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Vausselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"S\u00e9ron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Delfraissy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheline","family":"Misrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Cocquerel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"D Lavanchy","year":"2011","journal-title":"Clinical Microbiology and Infection"},{"issue":"Suppl 1","key":"ref2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"D Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.22.18888-en","article-title":"Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004","volume":"13","author":"C Larsen","year":"2008","journal-title":"Euro Surveill"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-10-303","article-title":"The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006\u20132010","volume":"10","author":"M-A Loko","year":"2010","journal-title":"BMC Infectious Diseases. BioMed Central Ltd"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"D Moradpour","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"H Barth","year":"2003","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"V Agnello","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"P Pileri","year":"1998","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"E Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"MJ Evans","year":"2007","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"A Ploss","year":"2009","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/JVI.01888-08","article-title":"Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection","volume":"83","author":"S Liu","year":"2009","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/JVI.01977-07","article-title":"The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus","volume":"82","author":"L Meertens","year":"2008","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1128\/JVI.01457-07","article-title":"Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus","volume":"81","author":"A Zheng","year":"2007","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"J Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1\u2013like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"B Sainz","year":"2012","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1073\/pnas.1301764110","article-title":"Identification of transferrin receptor 1 as a hepatitis C virus entry factor","volume":"110","author":"DN Martin","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e60333","DOI":"10.1371\/journal.pone.0060333","article-title":"PLOS ONE: Discovery of Cellular Proteins Required for the Early Steps of HCV Infection Using Integrative Genomics","volume":"8","author":"JH Park","year":"2013","journal-title":"PLoS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1128\/JVI.00024-06","article-title":"Hepatitis C virus entry depends on clathrin-mediated endocytosis","volume":"80","author":"E Blanchard","year":"2006","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1128\/JVI.01717-06","article-title":"Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles","volume":"80","author":"L Meertens","year":"2006","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","article-title":"Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry","volume":"80","author":"DM Tscherne","year":"2006","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1000702","DOI":"10.1371\/journal.ppat.1000702","article-title":"RNA interference and single particle tracking analysis of hepatitis C virus endocytosis","volume":"5","author":"KE Coller","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jmv.24088","article-title":"Claudin-1gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study)","volume":"87","author":"J Ghosn","year":"2015","journal-title":"J Med Virol"},{"key":"ref24","article-title":"Identification of variants of hepatitis C virus (HCV) entry factors in patients highly exposed to HCV but remaining uninfected: an ANRS case-control study","author":"B Fouquet","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.antiviral.2010.12.005","article-title":"Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity","volume":"89","author":"J Gentzsch","year":"2011","journal-title":"Antiviral Research"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/JVI.68.10.6147-6160.1994","article-title":"Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses","volume":"68","author":"J Dubuisson","year":"1994","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1128\/JVI.72.3.2183-2191.1998","article-title":"A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2","volume":"72","author":"L Cocquerel","year":"1998","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"B Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/JVI.78.6.2994-3002.2004","article-title":"Characterization of functional hepatitis C virus envelope glycoproteins","volume":"78","author":"A Op De Beeck","year":"2004","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"T Wakita","year":"2005","journal-title":"Nat Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1099\/vir.0.82872-0","article-title":"Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins","volume":"88","author":"D Delgrange","year":"2007","journal-title":"J Gen Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/JVI.01190-09","article-title":"Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication","volume":"84","author":"L Goueslain","year":"2010","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"JM Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1866","DOI":"10.1371\/journal.pone.0001866","article-title":"The CD81 partner EWI-2wint inhibits hepatitis C virus entry","volume":"3","author":"V Rocha-Perugini","year":"2008","journal-title":"PLoS ONE"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcv.2004.03.009","article-title":"TaqMan amplification system with an internal positive control for HCV RNA quantitation","volume":"31","author":"S Castelain","year":"2004","journal-title":"J Clin Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e70809","DOI":"10.1371\/journal.pone.0070809","article-title":"Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus","volume":"8","author":"F Helle","year":"2013","journal-title":"PLoS ONE"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations","volume":"51","author":"SE Krieger","year":"2010","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.gastro.2010.05.073","article-title":"Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes","volume":"139","author":"I Fofana","year":"2010","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nbt.3179","article-title":"Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody","volume":"33","author":"L Mailly","year":"2015","journal-title":"Nature Biotechnology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.02262-08","article-title":"Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts","volume":"83","author":"L Cukierman","year":"2009","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/JVI.02286-07","article-title":"CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry","volume":"82","author":"HJ Harris","year":"2008","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry","volume":"285","author":"HJ Harris","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1128\/JVI.00038-09","article-title":"The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection","volume":"83","author":"I Benedicto","year":"2009","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2010.08.009","article-title":"The second extracellular loop dictates Occludin-mediated HCV entry","volume":"407","author":"S Liu","year":"2010","journal-title":"Virology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1128\/JVI.01555-10","article-title":"Species-specific regions of occludin required by hepatitis C virus for cell entry","volume":"84","author":"ML Michta","year":"2010","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hep.20542","article-title":"Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus","volume":"41","author":"D Lavillette","year":"2005","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"J Zhong","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"11919","DOI":"10.1128\/JVI.01066-12","article-title":"Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells","volume":"86","author":"D Da Costa","year":"2012","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.26567","article-title":"Isolate-dependent use of claudins for cell entry by hepatitis C virus","volume":"59","author":"S Haid","year":"2014","journal-title":"Hepatology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e1003244","DOI":"10.1371\/journal.ppat.1003244","article-title":"Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies","volume":"9","author":"M Sourisseau","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"CL Brimacombe","year":"2011","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1128\/JVI.00212-11","article-title":"Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles","volume":"85","author":"S Ciesek","year":"2011","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1128\/JVI.00016-15","article-title":"Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach","volume":"89","author":"F Graw","year":"2015","journal-title":"J Virol"},{"key":"ref55","first-page":"8865","article-title":"A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR\/Cas9 Library Screening of the Hepatitis C Virus","volume":"5","author":"Q Ren","year":"2015","journal-title":"Nature Publishing Group"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/cmi.12112","article-title":"EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry","volume":"15","author":"J Potel","year":"2013","journal-title":"Cell Microbiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/JVI.01894-07","article-title":"Effect of cell polarization on hepatitis C virus entry","volume":"82","author":"CJ Mee","year":"2008","journal-title":"J Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1128\/JVI.00246-09","article-title":"Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells","volume":"83","author":"CJ Mee","year":"2009","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/cmi.12047","article-title":"Hepatoma polarization limits CD81 and hepatitis C virus dynamics","author":"HJ Harris","year":"2013","journal-title":"Cell Microbiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1128\/JVI.01059-06","article-title":"Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells","volume":"80","author":"B Sainz","year":"2006","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"P Farci","year":"2000","journal-title":"Science"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/jhep.2003.50019","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load","volume":"37","author":"H Hofer","year":"2003","journal-title":"Hepatology"},{"key":"ref63","first-page":"80","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"JT Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"ref64","first-page":"798","article-title":"Genetic variation in IL28B and spontaneous clearanceof hepatitis C virus","volume":"461","author":"DL Thomas","year":"2009","journal-title":"Nature. Nature Publishing Group"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"V Suppiah","year":"2009","journal-title":"Nature Genetics"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon","volume":"41","author":"Y Tanaka","year":"2009","journal-title":"Nature Genetics. Nature Publishing Group"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"L Prokunina-Olsson","year":"2013","journal-title":"Nature Genetics. Nature Publishing Group"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref69","first-page":"1","article-title":"Accepted Manuscript","author":"TR O'Brien","year":"2015","journal-title":"Journal of Hepatology. European Association for the Study of the Liver"},{"key":"ref70","first-page":"30","article-title":"Host factors involved in low susceptibility to HIV infection","volume":"13","author":"C Restrepo","year":"2011","journal-title":"AIDS Rev"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"M Samson","year":"1996","journal-title":"Nature"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2013.10.018","article-title":"Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization","volume":"101","author":"M Deest","year":"2014","journal-title":"Antiviral Research. Elsevier B.V"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:29:48Z","timestamp":1653524988000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142539"}},"subtitle":[],"editor":[{"given":"Ratna B.","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,12]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142539","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,12]]}}}